All terms in MeSH

Label Id Description
Soil Erosion G01.311.865
Tomography, Spiral Computed D036542 [Computed tomography where there is continuous X-ray exposure to the patient while being transported in a spiral or helical pattern through the beam of irradiation. This provides improved three-dimensional contrast and spatial resolution compared to conventional computed tomography, where data is obtained and computed from individual sequential exposures. ]
Cyproterone D04.210.500.883.419
Complement C5 Convertase, Classical Pathway D12.776.124.486.274.045.387.750.750
ADP-ribosyl Cyclase D036541 [A membrane-bound or cytosolic enzyme that catalyzes the synthesis of CYCLIC ADP-RIBOSE (cADPR) from nicotinamide adenine dinucleotide (NAD). This enzyme generally catalyzes the hydrolysis of cADPR to ADP-RIBOSE, as well, and sometimes the synthesis of cyclic ADP-ribose 2' phosphate (2'-P-cADPR) from NADP. , EC 3.2.2.5 ]
Arthroplasty, Replacement, Elbow E04.650.110.045
Scleral Buckling D012591 [An operation for retinal detachment which reduces the size of the globe by indenting the sclera so that it approximates the retina. ]
Scleredema Adultorum D012592 [A diffuse, non-pitting induration of the skin of unknown etiology that occurs most commonly in association with diabetes mellitus, predominantly in females. It typically begins on the face or head and spreads to other areas of the body, sometimes involving noncutaneous tissues. Often it is preceded by any of various infections, notably staphylococcal infections. The condition resolves spontaneously, usually within two years of onset. (From Dorland, 27th ed) ]
Sclerema Neonatorum D012593 [A severe, sometimes fatal, disorder of adipose tissue occurring chiefly in preterm or debilitated infants suffering from an underlying illness and manifested by a diffuse, nonpitting induration of the affected tissue. The skin becomes cold, yellowish, mottled, and inflexible. ]
Scleroderma, Localized D012594 [A term used to describe a variety of localized asymmetrical SKIN thickening that is similar to those of SYSTEMIC SCLERODERMA but without the disease features in the multiple internal organs and BLOOD VESSELS. Lesions may be characterized as patches or plaques (morphea), bands (linear), or nodules. ]
Glycogen Storage Disease Type IIb C10.597.606.360.455.562
Scleroderma, Systemic D012595 [A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. ]
Scleroproteins D012596 [Simple proteins characterized by their insolubility and fibrous structure. Within the body, they perform a supportive or protective function. ]
Wildfires N06.230.216.875
Sclerosing Solutions D012597 [Chemical agents injected into blood vessels and lymphatic sinuses to shrink or cause localized THROMBOSIS; FIBROSIS, and obliteration of the vessels. This treatment is applied in a number of conditions such as VARICOSE VEINS; HEMORRHOIDS; GASTRIC VARICES; ESOPHAGEAL VARICES; PEPTIC ULCER HEMORRHAGE. ]
Sclerosis D012598 [A pathological process consisting of hardening or fibrosis of an anatomical structure, often a vessel or a nerve. ]
Hypopituitarism C19.700.482
Oliguria C23.888.942.400
Insulin Infusion Systems E02.319.300.508
Plasma Volume G09.188.130.610